Skip Navigation
medication-assisted treatment for substance use disorders

Opioid Treatment Program Certification

Overview

Certification is the process by which the SAMHSA/CSAT Division of Pharmacologic Therapies (DPT) determines that an OTP is qualified to provide opioid treatment under 42 CFR Part 8.

To obtain SAMHSA certification OTPs must successfully complete the accreditation process and meet other requirements enumerated in 42 CFR Part 8. A program may apply to SAMHSA for provisional (initial) certification during the time it is working towards accreditation with a SAMHSA-approved accrediting body. Provisional certification is a temporary certification granted for up to one year to a new OTP during which time it must become accredited.

Upon achieving accreditation a provisionally certified OTP may apply to SAMHSA for renewal (full) certification. Once certified, programs must renew certification at least every three years. For an overview of the OTP accreditation and certification processes, view the Opioid Treatment Regulation page.

Programs applying for accreditation or certification must also comply with the applicable statutes and regulations in their states. Contact information for State Opioid Treatment Authorities can be found on the State Opioid Treatment Authority page.

Applying to SAMHSA for Initial or Renewal OTP Certification

Application to SAMHSA for provisional (initial) certification of a new OTP, or renewal certification of an existing OTP, is made using Form SMA-162, Application for Certification to Use Opioid Drugs in Treatment.

Follow the appropriate link below for information on:

Notifying SAMHSA of Program Changes

Existing OTPs must notify SAMHSA within 3 weeks of either of the following program changes:

  • Change of Program Sponsor
  • Change of Medical Director

If Program does not have a Sponsor with an Extranet account, then click here to submit an SMA-162.

In addition, existing OTPs must apply to SAMHSA to receive approval for:

  • Relocation
  • Addition of new medical units (satellite clinics or mobile units)

Additional information about notifying SAMHSA of program changes is available on the instruction page.

For More Information

For more information about OTP certification and opening a treatment program contact the following people according to the state:

Region map
Region 1-Boston: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont
Region 2-New York: New Jersey, New York, Puerto Rico, the Virgin Islands
Nichole Smith pic Nichole Smith (Ivette Ruiz until April)
Public Health Advisor
Division of Pharmacologic Therapies
SAMHSA Center for Substance Abuse Treatment
nichole.smith@samhsa.hhs.gov
Voice: 240.276.2719
Fax: 240.276.2710
Ivette Ruiz
Ivette.ruiz@samhsa.hhs.gov
Voice: 240.276.1511
Fax: 240.276.2710
Region 3 - Philadelphia: Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, West Virginia
Region 10 - Seattle: Alaska, Idaho, Oregon, Washington
Steve Mason pic Steve Mason
Public Health Advisor
Division of Pharmacologic Therapies
SAMHSA Center for Substance Abuse Treatment
steve.mason@samhsa.hhs.gov
Voice: 240.276.2901
Fax: 240.276.2710
Region 4 - Atlanta: Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee
Region 7 - Kansas City: Iowa, Kansas, Missouri, Nebraska
Todd Rosendale pic Todd Rosendale
Public Health Advisor
Division of Pharmacologic Therapies
SAMHSA Center for Substance Abuse Treatment
todd.rosendale@samhsa.hhs.gov
Voice: 240.276.2717
Fax: 240.276.2710
Region 5 - Chicago: Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin
Region 6 - Dallas: Arkansas, Louisiana, New Mexico, Oklahoma, Texas
Johnson pic Brandon Johnson
Public Health Advisor
Division of Pharmacologic Therapies
SAMHSA Center for Substance Abuse Treatment
brandon.johnson@samhsa.hhs.gov
Voice: 240.276.2889
Fax: 240.238.9459
Region 8 - Denver: Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming
Region 9 - San Francisco: Arizona, California, Hawaii, Nevada, American Samoa, Commonwealth of the Northern Mariana Islands
Mary Lou Ojeda pic Mary Lou Ojeda
Public Health Advisor
Division of Pharmacologic Therapies
SAMHSA Center for Substance Abuse Treatment
mary.ojeda@samhsa.hhs.gov
Voice: 240.276.2894
Fax: 240.276.2710

The mailing address for the above listed personnel is:

  • Division of Pharmacologic Therapies
    Center for Substance Abuse Treatment
    SAMHSA
    1 Choke Cherry Rd.
    Rockville, MD 20857
    (Overnight: 20850)

SMA-162 forms can completed in paper form and faxed or mailed to SAMHSA and (where applicable) the State Opioid Treatment Authority.

PDF File*PDF formatted files require that Adobe Acrobat Reader® program.
Follow this link to download this FREE software now from Adobe.
 
Note to users of screen readers and other assistive technologies: Please report your problems
to us at otp-extranet@opioid.samhsa.gov.
link to the Substance Abuse & Mental Health Services Administration division of pharmacologic therapies logo